An Interest In:
Web News this Week
- March 30, 2024
- March 29, 2024
- March 28, 2024
- March 27, 2024
- March 26, 2024
- March 25, 2024
- March 24, 2024
Some of Our Sources
- TutsPlus - Code
- TutsPlus - Design
- Vandelay Design
- Naldz Graphics
- Crazy Leaf Design
- Fudge Graphics
- Spyre Studios
- Android Dissected
- Android Headlines
- Hashedout
Help Webnuz
Referal links:
September 9, 2017 07:25 pm GMT
The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders from the Food and Drug Administration that 23andMe cease sales of its consumer health report product, which drove a major portion of both 23andMe’s revenue and brand awareness at the… Read More
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/XrqOU4PN5wY/
23andMes second act sits squarely in drug research and development
The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders from the Food and Drug Administration that 23andMe cease sales of its consumer health report product, which drove a major portion of both 23andMe’s revenue and brand awareness at the… Read MoreOriginal Link: http://feedproxy.google.com/~r/Techcrunch/~3/XrqOU4PN5wY/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch